JP2008255122A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008255122A5 JP2008255122A5 JP2008130502A JP2008130502A JP2008255122A5 JP 2008255122 A5 JP2008255122 A5 JP 2008255122A5 JP 2008130502 A JP2008130502 A JP 2008130502A JP 2008130502 A JP2008130502 A JP 2008130502A JP 2008255122 A5 JP2008255122 A5 JP 2008255122A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- alkyl
- methyl
- olefin containing
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000001336 alkenes Chemical class 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- 150000003222 pyridines Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 150000003333 secondary alcohols Chemical group 0.000 claims 3
- ASEHPOZWQJRWAD-UHFFFAOYSA-N 3-bromo-5-propan-2-yloxypyridine Chemical group CC(C)OC1=CN=CC(Br)=C1 ASEHPOZWQJRWAD-UHFFFAOYSA-N 0.000 claims 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-Toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 claims 2
- 150000001412 amines Chemical group 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000001808 coupling Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- 238000005859 coupling reaction Methods 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 230000002194 synthesizing Effects 0.000 claims 2
- VGHPZVGOJRVPEH-MALLOTDXSA-N (E,2S)-5-(5-propan-2-yloxypyridin-3-yl)pent-4-en-2-ol Chemical group CC(C)OC1=CN=CC(\C=C\C[C@H](C)O)=C1 VGHPZVGOJRVPEH-MALLOTDXSA-N 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims 1
- -1 p-toluenesulfonate ester Chemical class 0.000 claims 1
- ZHZCYWWNFQUZOR-UHFFFAOYSA-N pent-4-en-2-ol Chemical group CC(O)CC=C ZHZCYWWNFQUZOR-UHFFFAOYSA-N 0.000 claims 1
- MGFRWLSGAABYES-UHFFFAOYSA-N tert-butyl N-methyl-N-pent-4-en-2-ylcarbamate Chemical group C=CCC(C)N(C)C(=O)OC(C)(C)C MGFRWLSGAABYES-UHFFFAOYSA-N 0.000 claims 1
Claims (11)
- 式中、R’がイソプロピルであり;波線部の配置がトランス(E)形であり;E VI がメチルであり;Z’が水素であり;Z”がメチルである、請求項1に記載の方法。
- ハロ置換ピリジンが3−ブロモ−5−イソプロポキシピリジンである、請求項2に記載の方法。
- 二級アルコール官能基性を含むオレフィンが4−ペンテン−2−オールである、請求項3に記載の方法。
- p−トルエンスルホニルクロリドで処理することによりp−トルエンスルホネートエステルに変換することをさらに含む、請求項4に記載の方法。
- メチルアミンで処理することをさらに含む、請求項5に記載の方法。
- 二級アルコール官能基性を含むオレフィンが(2S)−(4E)−5−(5−イソプロポキシ−3−ピリジル)−4−ペンテン−2−オールである、請求項1に記載の方法。
- 式中、R’がイソプロピルであり;波線部の配置がトランス(E)形であり;E VI がメチルであり;Z’が水素であり;Z”がメチルである、請求項8に記載の方法。
- ハロ置換ピリジンが3−ブロモ−5−イソプロポキシピリジンである、請求項9に記載の方法。
- 保護アミン官能基性を含むオレフィンがN−メチル−N−(tert−ブトキシカルボニル)−4−ペンテン−2−アミンである、請求項10に記載の方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9828598A | 1998-06-16 | 1998-06-16 | |
US09/098,285 | 1998-06-16 | ||
US09/098,133 US6232316B1 (en) | 1998-06-16 | 1998-06-16 | Methods for treatment of CNS disorders |
US09/098,133 | 1998-06-16 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000554703A Division JP4240815B2 (ja) | 1998-06-16 | 1999-06-03 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010135746A Division JP2010229149A (ja) | 1998-06-16 | 2010-06-15 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008255122A JP2008255122A (ja) | 2008-10-23 |
JP2008255122A5 true JP2008255122A5 (ja) | 2010-07-22 |
JP4972608B2 JP4972608B2 (ja) | 2012-07-11 |
Family
ID=26794206
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000554703A Expired - Fee Related JP4240815B2 (ja) | 1998-06-16 | 1999-06-03 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
JP2008130502A Expired - Fee Related JP4972608B2 (ja) | 1998-06-16 | 2008-05-19 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
JP2008130504A Expired - Fee Related JP4896923B2 (ja) | 1998-06-16 | 2008-05-19 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
JP2010135746A Pending JP2010229149A (ja) | 1998-06-16 | 2010-06-15 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000554703A Expired - Fee Related JP4240815B2 (ja) | 1998-06-16 | 1999-06-03 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008130504A Expired - Fee Related JP4896923B2 (ja) | 1998-06-16 | 2008-05-19 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
JP2010135746A Pending JP2010229149A (ja) | 1998-06-16 | 2010-06-15 | アリール置換オレフィンアミンと、コリン受容体アゴニストとしてのアリール置換オレフィンアミンの使用 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1086082B9 (ja) |
JP (4) | JP4240815B2 (ja) |
KR (1) | KR100593433B1 (ja) |
AT (1) | ATE273956T1 (ja) |
AU (1) | AU4230799A (ja) |
BR (1) | BR9911325A (ja) |
CA (3) | CA2677519A1 (ja) |
DE (1) | DE69919537T2 (ja) |
DK (1) | DK1086082T3 (ja) |
ES (1) | ES2228054T3 (ja) |
PT (1) | PT1086082E (ja) |
WO (1) | WO1999065876A1 (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6979695B2 (en) * | 1996-04-23 | 2005-12-27 | Targacept, Inc. | Compounds capable of activating cholinergic receptors |
AU4230799A (en) * | 1998-06-16 | 2000-01-05 | Targacept, Inc. | Aryl substituted olefinic amines and their use as cholinergic receptors agonists |
CA2376061A1 (en) * | 1999-06-07 | 2000-12-14 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
CA2383307A1 (en) * | 1999-08-31 | 2001-03-08 | Jared Miller Wagner | Arylalkyloxyalkylamines and arylalkylthioalkylamines, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
AU2001257449A1 (en) * | 2000-05-01 | 2001-11-12 | Targacept, Inc. | Imaging of nicotinic acetylcholine receptor subtypes |
US6432954B1 (en) * | 2000-07-14 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
CN100371714C (zh) | 2001-12-14 | 2008-02-27 | 塔加西普特公司 | 治疗中枢神经系统病症的方法和组合物 |
US8580842B2 (en) | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
PL1678172T3 (pl) | 2003-10-15 | 2010-05-31 | Targacept Inc | Związki azabicykliczne do łagodzenia bólu oraz leczenia zaburzeń centralnego układu nerwowego |
UA88792C2 (ru) * | 2004-11-10 | 2009-11-25 | Таргасепт, Інк. | Гидроксибензоатные соли метаникотиновых соединений |
US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
TWI389889B (zh) | 2006-05-09 | 2013-03-21 | Targacept Inc | (2s)-(4e)-n-甲基-5-〔3-(5-異丙氧基吡啶)基〕-4-戊烯-2-胺之新穎多晶型 |
EP2357174A1 (en) | 2006-05-09 | 2011-08-17 | AstraZeneca AB | Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine |
WO2008028903A2 (en) | 2006-09-04 | 2008-03-13 | Neurosearch A/S | Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer |
US20080167286A1 (en) | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
US8486979B2 (en) | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
UY30846A1 (es) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos |
EP2182932A2 (en) * | 2007-07-31 | 2010-05-12 | Targacept Inc. | Transdermal administration of (2s)-(4e)-n-methyl-5-(3-(5-isopropoxypyridin)yl)-4-penten-2-amine |
CN102026995B (zh) | 2007-12-07 | 2014-10-29 | Abbvie德国有限责任两合公司 | 5,6-二取代的羟吲哚衍生物和其用途 |
MX2010006202A (es) | 2007-12-07 | 2011-03-04 | Abbott Gmbh & Co Kg | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. |
US8703774B2 (en) | 2007-12-07 | 2014-04-22 | AbbVie Deutschland GmbH & Co. KG | Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
JP5595926B2 (ja) | 2007-12-07 | 2014-09-24 | アボット ゲーエムベーハー ウント カンパニー カーゲー | 5−ハロゲン−置換オキシインドール誘導体およびバソプレッシン依存性疾患の治療へのこれらの使用 |
US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
WO2009146031A1 (en) | 2008-03-31 | 2009-12-03 | University Of South Florida | Methods of treating disease-induced ataxia and non-ataxic imbalance |
WO2010138600A2 (en) | 2009-05-29 | 2010-12-02 | Abbott Laboratories | Pharmaceutical compositions for the treatment of pain |
SG185497A1 (en) * | 2010-05-20 | 2012-12-28 | Astrazeneca Ab | New process for the preparation of aryl substituted olefinic amines |
WO2013184732A1 (en) * | 2012-06-06 | 2013-12-12 | Targacept, Inc. | Crystalline (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]4-penten-2-amine 1,5-naphthalenedisulfonate |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242935A (en) * | 1992-03-06 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5597716A (en) * | 1993-11-18 | 1997-01-28 | Mitsubishi Rayon Co., Ltd. | Process for producing D-lactic acid and L-lactamide |
US5597919A (en) * | 1995-01-06 | 1997-01-28 | Dull; Gary M. | Pyrimidinyl or Pyridinyl alkenyl amine compounds |
US5616707A (en) * | 1995-01-06 | 1997-04-01 | Crooks; Peter A. | Compounds which are useful for prevention and treatment of central nervous system disorders |
EP0801527B1 (en) * | 1995-01-06 | 2006-07-26 | Targacept, Inc. | Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
WO1996036637A1 (en) * | 1995-05-17 | 1996-11-21 | R.J. Reynolds Tobacco Company | Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
US5616716A (en) * | 1996-01-06 | 1997-04-01 | Dull; Gary M. | (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
ES2318856T4 (es) * | 1996-04-23 | 2010-03-03 | Targacept, Inc. | Composiciones farmaceuticas para la prevencion y el tratamiento de trastornos del sistema nervioso central. |
US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
ATE274496T1 (de) * | 1997-02-21 | 2004-09-15 | Targacept Inc | Pharmazeutische zusammensetzungen welche aryl- substituierte olefinische amin-verbindungen enthalten |
AU4230799A (en) * | 1998-06-16 | 2000-01-05 | Targacept, Inc. | Aryl substituted olefinic amines and their use as cholinergic receptors agonists |
-
1999
- 1999-06-03 AU AU42307/99A patent/AU4230799A/en not_active Abandoned
- 1999-06-03 KR KR1020007014279A patent/KR100593433B1/ko not_active IP Right Cessation
- 1999-06-03 PT PT99926152T patent/PT1086082E/pt unknown
- 1999-06-03 AT AT99926152T patent/ATE273956T1/de active
- 1999-06-03 BR BR9911325-2A patent/BR9911325A/pt not_active Application Discontinuation
- 1999-06-03 JP JP2000554703A patent/JP4240815B2/ja not_active Expired - Fee Related
- 1999-06-03 DK DK99926152T patent/DK1086082T3/da active
- 1999-06-03 CA CA002677519A patent/CA2677519A1/en not_active Abandoned
- 1999-06-03 EP EP99926152A patent/EP1086082B9/en not_active Expired - Lifetime
- 1999-06-03 CA CA002334923A patent/CA2334923C/en not_active Expired - Fee Related
- 1999-06-03 CA CA2709735A patent/CA2709735A1/en not_active Abandoned
- 1999-06-03 ES ES99926152T patent/ES2228054T3/es not_active Expired - Lifetime
- 1999-06-03 DE DE69919537T patent/DE69919537T2/de not_active Expired - Lifetime
- 1999-06-03 WO PCT/US1999/012340 patent/WO1999065876A1/en active IP Right Grant
-
2008
- 2008-05-19 JP JP2008130502A patent/JP4972608B2/ja not_active Expired - Fee Related
- 2008-05-19 JP JP2008130504A patent/JP4896923B2/ja not_active Expired - Fee Related
-
2010
- 2010-06-15 JP JP2010135746A patent/JP2010229149A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008255122A5 (ja) | ||
JP2010500343A5 (ja) | ||
EP2592070A3 (en) | Tetrazole-substituted arylamides | |
SI2601177T1 (en) | N-acylsulfonamide apoptosis promoters | |
JP2012144574A5 (ja) | ||
RU2009135621A (ru) | Хинолиновые производные для лечения воспалительных заболеваний | |
JP2007510619A5 (ja) | ||
JP2006151984A5 (ja) | ||
JP2010533727A5 (ja) | ||
JP2009523760A5 (ja) | ||
JP2008540414A5 (ja) | ||
JP2011520815A5 (ja) | ||
JP2008511618A5 (ja) | ||
EP2308828A3 (en) | CaSR antagonist | |
JP2011523952A5 (ja) | ||
MX2009003739A (es) | Derivados de hidrobenzamida como inhibidores de hsp90. | |
JP2010529994A5 (ja) | ||
JP2011524871A5 (ja) | ||
JP2012513390A5 (ja) | ||
JP2001261662A5 (ja) | ||
RU2015122032A (ru) | Оксазолидинонсодержащие соединения, композиции и способы их использования | |
JP2004529172A5 (ja) | ||
JP2010507590A5 (ja) | ||
JP2006511482A5 (ja) | ||
JP2011527678A5 (ja) |